共 50 条
Employer-based patient-centered medication therapy management program: Evidence and recommendations for future programs
被引:21
|作者:
Shimp, Leslie A.
[1
]
Kucukarslan, Suzan N.
[1
]
Elder, Jodie
[1
]
Remington, Tami
[1
,2
]
Wells, Trisha
[1
,2
]
Choe, Hae Mi
[1
,3
]
Lewis, Nancy J. W.
[1
]
Kirking, Duane M.
[1
,4
]
机构:
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[3] Univ Michigan Hlth Syst, Innovat Ambulatory Care Pharm Practices, Ann Arbor, MI USA
[4] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
关键词:
Medication therapy management;
patient-centered care;
medication-related problems;
ECONOMIC OUTCOMES;
ILLNESS PERCEPTIONS;
SELF-MANAGEMENT;
PHARMACIST;
HEALTH;
QUESTIONNAIRE;
ADHERENCE;
PROJECT;
COLLABORATION;
HYPERTENSION;
D O I:
10.1331/JAPhA.2012.11186
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Objective: To evaluate a patient-centered employer-based medication therapy management (MTM) program. Design: Randomized controlled study. Setting: Health promotion program at the University of Michigan from June 2009 to December 2011. Participants: Employees, retirees, and their dependents taking seven or more prescription medications. Intervention: Focus on Medicines (FOM) was a two-visit, patient-centered service with a 4-month follow-up. A comprehensive medication review occurred during the first visit. Pharmacists provided recommendations and a medication action plan at the second visit. The MAP incorporated patient preferences for problem resolution. Main outcome measures: Patient uptake, medication cost, medication adherence, patient satisfaction with treatment, patient reasons for participation, patient satisfaction with the FOM program, drug-related problems, pharmacist recommendations, implementation of recommendations. Results: The FOM program attracted 128 individuals wanting information about their medications and an individualized drug regimen assessment to ensure that their therapy was safe and effective and that all medications were necessary. On average, 3.3 medication therapy problems were identified per patient; most were safety related. Overall, 63% of pharmacist recommendations were implemented. When a prescriber was contacted, 83% of pharmacist recommendations were implemented. A reduction in drug cost for patients and the employer was shown. Patients reported improved convenience in taking medications and rated the program favorably. Conclusion: A personalized dialogue about medication use appears to meet a need among individuals taking large numbers of medications. Understanding why patients participate in MTM programs and what program features patients appreciate is useful in designing quality MTM programs.
引用
收藏
页码:768 / 776
页数:9
相关论文